•
Clostridium thermocellum can use lignocellulosic waste and generate ethanol, thus making it a possible candidate for use in production of
ethanol fuel. It also has no oxygen requirement and is
thermophilic, which reduces cooling cost. •
Clostridium acetobutylicum was first used by
Chaim Weizmann to produce
acetone and
biobutanol from
starch in 1916 for the production of
cordite (smokeless gunpowder) in the
Weizmann process. •
Clostridium botulinum produces a potentially lethal
neurotoxin used in a diluted form in the drug
Botox, which is carefully injected to nerves in the face, which prevents the movement of the expressive muscles of the forehead, to delay the wrinkling effect of aging. It is also used to treat
spasmodic torticollis and provides relief for around 12 to 16 weeks. • Some clostridia that cause gas gangrene produce
hyaluronidase,
deoxyribonuclease,
lecithinase,
leukocidin,
protease,
lipase, and
hemolysin. •
Clostridium ljungdahlii, recently discovered in commercial chicken wastes, can produce ethanol from single-carbon sources including
synthesis gas, a mixture of
carbon monoxide and
hydrogen, that can be generated from the partial
combustion of either
fossil fuels or
biomass. • Genes from
Clostridium thermocellum have been inserted into
transgenic mice to allow the production of
endoglucanase. The experiment was intended to learn more about how the digestive capacity of
monogastric animals could be improved. • Nonpathogenic strains of
Clostridium may help in the treatment of diseases such as
cancer. Research shows that
Clostridium can selectively target cancer cells. Some strains can enter and replicate within solid
tumors.
Clostridium could, therefore, be used to deliver therapeutic proteins to tumours. This use of
Clostridium has been demonstrated in a variety of preclinical models. == References ==